Sign Up to like & get
recommendations!
0
Published in 2019 at "BMJ Open"
DOI: 10.1136/bmjopen-2018-028017
Abstract: Introduction Anti-platelet therapy, angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers, beta-blockers and statins are cost-effective in patients with atherosclerotic cardiovascular diseases (ASCVD) for reducing the risk of ASCVD events. Unfortunately, there is abundant evidence that adherence…
read more here.
Keywords:
trial;
adherence cardiovascular;
cardiovascular medications;
txt2heart ... See more keywords